These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 136099)
1. The influence of platelet aggregation inhibitors on metastasis formation in mice (3LL). Hilgard P; Heller H; Schmidt CG Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):243-50. PubMed ID: 136099 [TBL] [Abstract][Full Text] [Related]
2. Study of platelet aggregation in vivo: II. Effect of bencyclan on circulating metastatic tumor cells. Gastpar H; Ambrus J; Thurber LE J Med; 1977; 8(1):53-6. PubMed ID: 267156 [TBL] [Abstract][Full Text] [Related]
3. Platelet aggregation inhibitors in the prevention of metastasis in neoplastic disease: a review of experimental and clinical investigations. Gastpar H; Ambrus JL; Ambrus CM J Med; 1981; 12(1):15-33. PubMed ID: 6943264 [No Abstract] [Full Text] [Related]
4. Platelet turnover in metastatic cancer and the effect of platelet aggregation inhibitors. Abrahamsen AF Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 May; 86(1):109-111. PubMed ID: 132024 [TBL] [Abstract][Full Text] [Related]
5. [Modification of metastasis formation by inhibition of platelet aggregation. Experimental and clinical results]. Gastpar H Laryngol Rhinol Otol (Stuttg); 1983 Dec; 62(12):578-85. PubMed ID: 6369051 [TBL] [Abstract][Full Text] [Related]
6. Platelet-aggregating activities of metastasizing tumor cells. II. Variety of the aggregation mechanisms. Tohgo A; Tanaka N; Ashida S; Ogawa H Invasion Metastasis; 1984; 4(3):134-45. PubMed ID: 6480287 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454. Amirkhosravi A; Mousa SA; Amaya M; Blaydes S; Desai H; Meyer T; Francis JL Thromb Haemost; 2003 Sep; 90(3):549-54. PubMed ID: 12958625 [TBL] [Abstract][Full Text] [Related]
8. [The effect of bencyclan on shear induced platelet aggregation (author's transl)]. Klose HJ; Rieger H; Schmid-Schönbein H Arzneimittelforschung; 1975 Jul; 25(7):1064-7. PubMed ID: 1174412 [TBL] [Abstract][Full Text] [Related]
9. Effects of ticlopidine on metastasis production in mice bearing Lewis lung carcinoma. Fabra A; de Castellarnau C; Carretero F; Martínez E; Sancho MJ; Rutllant ML Invasion Metastasis; 1987; 7(1):53-60. PubMed ID: 3583621 [TBL] [Abstract][Full Text] [Related]
10. [Inhibitory activity of bencyclan on platelet aggregation in vitro and in vivo (author's transl)]. Jäger W; Scharrer I; Satkowski U; Breddin K Arzneimittelforschung; 1975; 25(12):1938-44. PubMed ID: 1243666 [TBL] [Abstract][Full Text] [Related]
11. Antimetastatic effect of flurbiprofen and other platelet aggregation inhibitors. Mamytbeková A; Rezábek K; Kacerovská H; Grimová J; Svobodová J Neoplasma; 1986; 33(4):417-21. PubMed ID: 3762804 [TBL] [Abstract][Full Text] [Related]
12. Antimetastatic action of RX-RA 69, a new potent PDE-inhibitor in the Lewis lung carcinoma of the mouse. Lichtner R; Haarmann W Prog Clin Biol Res; 1982; 89():131-41. PubMed ID: 6287486 [TBL] [Abstract][Full Text] [Related]
13. Studies on platelet aggregation inhibitors in vivo. VIII. Effect of pentoxifylline on spontaneous tumor metastasis. Gordon S; Witul M; Cohen H; Sciandra J; Williams P; Gastpar H; Murphy GP; Ambrus JL J Med; 1979; 10(6):435-43. PubMed ID: 233697 [TBL] [Abstract][Full Text] [Related]
14. Effects of DN-9693, a new metastasis inhibitor, on murine hematogenous metastasis. Tanaka NG; Tohgo A; Ogawa H; Osada Y Anticancer Res; 1986; 6(4):543-8. PubMed ID: 3019218 [TBL] [Abstract][Full Text] [Related]
15. Study of platelet aggregation in vivo i. Effect of bencyclan. Ambrus JL; Ambrus CM; Gastpar H; Sapvento PJ; Weber FJ; Thurber LE J Med; 1976; 7(6):439-47. PubMed ID: 827596 [TBL] [Abstract][Full Text] [Related]
16. Effect of RA233 alone and combined with radiation on experimental tumour metastasis. Part 1. Li XT; Hellmann K Clin Exp Metastasis; 1983; 1(1):51-9. PubMed ID: 6543684 [TBL] [Abstract][Full Text] [Related]
17. [Effect of bencyclan and theophylline on changes of platelet aggregation and factor 3 activity]. Losonczy H; Nagy I; Szaksz I Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):853-60. PubMed ID: 94878 [TBL] [Abstract][Full Text] [Related]
18. Platelet-aggregating activities of metastasizing tumor cells. V. In situ roles of platelets in hematogenous metastases. Tanaka NG; Tohgo A; Ogawa H Invasion Metastasis; 1986; 6(4):209-24. PubMed ID: 3759361 [TBL] [Abstract][Full Text] [Related]
19. On thrombocytopenia developing in mice bearing a spontaneously metastasizing tumor. Poggi A; Donati MB; Polentarutti N; de Gaetano G; Garattini S Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):303-6. PubMed ID: 136105 [TBL] [Abstract][Full Text] [Related]
20. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood). Violi F; Praticò D; Iuliano L; Balsano F J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]